Back to dashboard
CommercialCoverageMedium impact

Zurzuvae (zuranolone)

Blue Cross & Blue Shield of Mississippi·MS · OB-GYN, Psychiatry, Family Medicine +1 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Zurzuvae (zuranolone) for postpartum depression is considered not medically necessary by BCBS Mississippi, as other covered alternatives exist for treating postpartum depression. State Health Plan employees may have coverage through their pharmacy benefit manager with prior authorization.

Action Required

Action needed
Immediately: Before prescribing Zurzuvae for postpartum depression, providers must perform formulary drug search on patient's member ID to verify coverage. For State Health Plan patients, check https://www.dfa.ms.gov/cvs-caremark and submit prior authorization requests to the pharmacy benefit manager. Billing team should expect denials for Zurzuvae unless patient has State Health Plan coverage with approved prior authorization.